Welcome to the fifth episode of the Raw Talk Podcast. The theme for this month is “Neurotrauma”. In our first instalment, surgeon-scientist Dr. Michael Fehlings joins us to speak about his early training in spinal cord injury (both in surgery and research), the translational potential of his current research, and anticipated lecture at the upcoming Charles H. Tator – Barbara Turnbull Spinal Cord Injury Symposium. More information on this symposium is provided below.
Dr. Fehlings’ early research career focussed on the detrimental effects of ischemia in patients with spine and spinal cord injuries. His PhD thesis, which Dr. Fehlings’ terms the “ischemic hypothesis of secondary injury” has been seminal to the past two decades of central nervous system injury prevention and treatment research. The genesis and impact of this work is covered in our very first “Classics” segment.
Advancing this work with his current laboratory focus, Dr. Fehlings’ utilizes neural stem cells coupled with bioengineering strategies to treat spinal cord injury and cerebral palsy, using animal models to marry his basic science work to spinal cord injury. Moreover, Dr. Fehlings’ discusses his current involvement with an on-going clinical trial and how important it is to translate experimental discoveries to the clinic.
We wrap up the conversation with Dr. Fehlings’ former supervisor and long-standing collaborator, Dr. Charles Tator in “Mentor’s Corner”. In this segment, Dr. Tator describes his personal and professional relationship with Dr. Fehlings and gives his advice to those interested in pursuing concussion and spinal cord research.
Until next time, Keep it Raw!
15th Annual Charles H. Tator – Barbara Turnbull Spinal Cord Injury Symposium: